Correlation Between Vigil Neuroscience and Rani Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Vigil Neuroscience and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Rani Therapeutics.

Diversification Opportunities for Vigil Neuroscience and Rani Therapeutics

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Vigil and Rani is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Rani Therapeutics go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Rani Therapeutics

Given the investment horizon of 90 days Vigil Neuroscience is expected to generate 1.4 times more return on investment than Rani Therapeutics. However, Vigil Neuroscience is 1.4 times more volatile than Rani Therapeutics Holdings. It trades about 0.3 of its potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about -0.05 per unit of risk. If you would invest  177.00  in Vigil Neuroscience on November 2, 2024 and sell it today you would earn a total of  58.00  from holding Vigil Neuroscience or generate 32.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Vigil Neuroscience  vs.  Rani Therapeutics Holdings

 Performance 
       Timeline  
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Rani Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rani Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Vigil Neuroscience and Rani Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vigil Neuroscience and Rani Therapeutics

The main advantage of trading using opposite Vigil Neuroscience and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.
The idea behind Vigil Neuroscience and Rani Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stocks Directory
Find actively traded stocks across global markets